Cutler Group’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,200
Closed -$23K 4243
2023
Q2
$23K Sell
1,200
-2,363
-66% -$45.5K ﹤0.01% 1782
2023
Q1
$67K Buy
3,563
+2,707
+316% +$59.9K 0.01% 1179
2022
Q4
$19K Buy
856
+636
+289% +$14.4K ﹤0.01% 2259
2022
Q3
$5K Sell
220
-380
-63% -$11.3K ﹤0.01% 3686
2022
Q2
$14K Buy
+600
New +$15K ﹤0.01% 2965
2021
Q4
Sell
-1,200
Closed -$50K 5928
2021
Q3
$50K Sell
1,200
-222
-16% -$7.99K ﹤0.01% 2510
2021
Q2
$55K Buy
1,422
+1,222
+611% +$43.7K ﹤0.01% 2414
2021
Q1
$6K Sell
200
-3,200
-94% -$136K ﹤0.01% 4263
2020
Q4
$154K Buy
+3,400
New +$119K 0.01% 1242
2020
Q2
Sell
-1,800
Closed -$67.1K 4777
2020
Q1
$58K Buy
1,800
+600
+50% +$25K ﹤0.01% 1639
2019
Q4
$49K Buy
1,200
+300
+33% +$11.9K ﹤0.01% 1644
2019
Q3
$32K Sell
900
-6,400
-88% -$259K ﹤0.01% 1848
2019
Q2
$375K Buy
7,300
+4,400
+152% +$220K 0.03% 432
2019
Q1
$166K Sell
2,900
-1,300
-31% -$64.4K 0.02% 740
2018
Q4
$176K Sell
4,200
-1,400
-25% -$82.1K 0.02% 707
2018
Q3
$422K Buy
5,600
+5,233
+1,426% +$377K 0.03% 531
2018
Q2
$26K Sell
367
-533
-59% -$25.5K ﹤0.01% 2014
2018
Q1
$26K Sell
900
-7,357
-89% -$214K ﹤0.01% 2103
2017
Q4
$274K Buy
8,257
+4,504
+120% +$136K 0.01% 805
2017
Q3
$123K Buy
+3,753
New +$84.5K ﹤0.01% 1496

Other funds holding RGNX